Moreover, previous studies reveal that activated memory CD4 T cells have the least proportion in clinical stage IV of bladder cancer and are associated with beneficial prognosis, which may directly kill tumors or activate the body’s immune response to destroy the tumor cells (Li W. et al., 2020). This evidence concerns the gene CD4 and urinary bladder cancer.